| Dr Joseph Baird Askew, MD | |
|
1701 S Shackleford Rd, Little Rock, AR 72211-4335 | |
| (501) 219-7000 | |
| Not Available |
| Full Name | Dr Joseph Baird Askew |
|---|---|
| Gender | Male |
| Speciality | Emergency Medicine |
| Experience | 5 Years |
| Location | 1701 S Shackleford Rd, Little Rock, Arkansas |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1023579166 | NPI | - | NPPES |
| 232564795 | Medicaid | AR | |
| E-15309 | Other | AR | ARKANSAS STATE MEDICAL LICENSE |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207P00000X | Emergency Medicine | E-15309 (Arkansas) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Arkansas Heart Hospital, Llc | Little rock, AR | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Arkansas Heart Hospital Llc | 6002838653 | 90 |
News Archive
The study, considered the first of its kind, was conducted by researchers from MIT, Harvard and the state of Oregon and examined the impact of randomly assigning Medicaid insurance to poor Oregonians as part of the state's expansion of health coverage.
In the German Center for Infection Research (DZIF), scientists from the universities of Tübingen, Münster and Munich join forces and prepare together with the company Hyglos clinical studies on an active substance against the dreaded hospital pathogen Staphylococcus aureus: A highly effective protein from bacteria-specific viruses, so-called bacteriophages, shall rapidly kill the bacteria, which frequently occur in the nose.
AFFiRiS AG's clinical Alzheimer's vaccine candidate AD02 has already progressed to phase II clinical testing. It may therefore be possible to confirm the efficacy of the vaccine as early as during 2012. Indeed the start of this efficacy study comes only five months after the completion of the corresponding phase I study. The company is active in several disease areas and is currently developing a total of twelve prospective products in all stages of the development pipeline up to clinical phase II.
Women with early-stage breast cancer who have undergone breast augmentation may be treated successfully with a partial-breast radiation treatment called brachytherapy, according to a study presented today at the annual meeting of the Radiological Society of North America (RSNA).
BioOhio and partners have been awarded a $5 million grant from the U.S. Department of Labor Employment and Training Administration to implement the Ohio Bioscience Industry Workforce Preparedness project.
› Verified 1 days ago
| Entity Name | Arkansas Heart Hospital Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1558653212 PECOS PAC ID: 6002838653 Enrollment ID: O20110729000327 |
News Archive
The study, considered the first of its kind, was conducted by researchers from MIT, Harvard and the state of Oregon and examined the impact of randomly assigning Medicaid insurance to poor Oregonians as part of the state's expansion of health coverage.
In the German Center for Infection Research (DZIF), scientists from the universities of Tübingen, Münster and Munich join forces and prepare together with the company Hyglos clinical studies on an active substance against the dreaded hospital pathogen Staphylococcus aureus: A highly effective protein from bacteria-specific viruses, so-called bacteriophages, shall rapidly kill the bacteria, which frequently occur in the nose.
AFFiRiS AG's clinical Alzheimer's vaccine candidate AD02 has already progressed to phase II clinical testing. It may therefore be possible to confirm the efficacy of the vaccine as early as during 2012. Indeed the start of this efficacy study comes only five months after the completion of the corresponding phase I study. The company is active in several disease areas and is currently developing a total of twelve prospective products in all stages of the development pipeline up to clinical phase II.
Women with early-stage breast cancer who have undergone breast augmentation may be treated successfully with a partial-breast radiation treatment called brachytherapy, according to a study presented today at the annual meeting of the Radiological Society of North America (RSNA).
BioOhio and partners have been awarded a $5 million grant from the U.S. Department of Labor Employment and Training Administration to implement the Ohio Bioscience Industry Workforce Preparedness project.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Joseph Baird Askew, MD 1701 S Shackleford Rd, Little Rock, AR 72211-4335 Ph: (501) 219-7000 | Dr Joseph Baird Askew, MD 1701 S Shackleford Rd, Little Rock, AR 72211-4335 Ph: (501) 219-7000 |
News Archive
The study, considered the first of its kind, was conducted by researchers from MIT, Harvard and the state of Oregon and examined the impact of randomly assigning Medicaid insurance to poor Oregonians as part of the state's expansion of health coverage.
In the German Center for Infection Research (DZIF), scientists from the universities of Tübingen, Münster and Munich join forces and prepare together with the company Hyglos clinical studies on an active substance against the dreaded hospital pathogen Staphylococcus aureus: A highly effective protein from bacteria-specific viruses, so-called bacteriophages, shall rapidly kill the bacteria, which frequently occur in the nose.
AFFiRiS AG's clinical Alzheimer's vaccine candidate AD02 has already progressed to phase II clinical testing. It may therefore be possible to confirm the efficacy of the vaccine as early as during 2012. Indeed the start of this efficacy study comes only five months after the completion of the corresponding phase I study. The company is active in several disease areas and is currently developing a total of twelve prospective products in all stages of the development pipeline up to clinical phase II.
Women with early-stage breast cancer who have undergone breast augmentation may be treated successfully with a partial-breast radiation treatment called brachytherapy, according to a study presented today at the annual meeting of the Radiological Society of North America (RSNA).
BioOhio and partners have been awarded a $5 million grant from the U.S. Department of Labor Employment and Training Administration to implement the Ohio Bioscience Industry Workforce Preparedness project.
› Verified 1 days ago
Dr. Armando Leonel Martinez, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 4301 W Markham St, Slot 783, Little Rock, AR 72205 Phone: 501-686-8000 | |
Sikandar Murad, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 802 N University Ave, Little Rock, AR 72205 Phone: 501-291-2322 Fax: 888-388-5166 | |
David Gregory Hinckley, M.D. Emergency Medicine Medicare: Medicare Enrolled Practice Location: 1701 S Shackleford Rd, Little Rock, AR 72211 Phone: 501-219-7000 | |
Matt Saenz, Emergency Medicine Medicare: Medicare Enrolled Practice Location: 4301 W Markham St # 584, Little Rock, AR 72205 Phone: 501-526-7485 | |
Dr. Timothy W Calicott, M.D. Emergency Medicine Medicare: Not Enrolled in Medicare Practice Location: 14623 Chambery Dr, Little Rock, AR 72211 Phone: 501-920-8556 | |
Christopher Wade Fowler, DO Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 4301 W Markham St, Little Rock, AR 72205 Phone: 501-686-7000 |